Susquehanna International Group’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$400K Buy
116,346
+31,016
+36% +$107K ﹤0.01% 4629
2025
Q1
$182K Buy
85,330
+58,891
+223% +$125K ﹤0.01% 5574
2024
Q4
$84.3K Buy
26,439
+5,853
+28% +$18.7K ﹤0.01% 5737
2024
Q3
$275K Buy
+20,586
New +$275K ﹤0.01% 4415
2024
Q2
Sell
-53,529
Closed -$637K 5731
2024
Q1
$637K Buy
+53,529
New +$637K ﹤0.01% 3211
2023
Q4
Sell
-1,934
Closed -$5.29K 5997
2023
Q3
$5.29K Buy
1,934
+287
+17% +$785 ﹤0.01% 5384
2023
Q2
$11K Buy
+1,647
New +$11K ﹤0.01% 5428
2023
Q1
Sell
-1,935
Closed -$4.78K 6045
2022
Q4
$4.78K Buy
+1,935
New +$4.78K ﹤0.01% 5561
2022
Q3
Sell
-3,533
Closed -$11K 6180
2022
Q2
$11K Buy
3,533
+1,714
+94% +$5.34K ﹤0.01% 5486
2022
Q1
$7K Sell
1,819
-14,689
-89% -$56.5K ﹤0.01% 5582
2021
Q4
$64K Buy
+16,508
New +$64K ﹤0.01% 5420
2021
Q2
Sell
-2,534
Closed -$28K 5367
2021
Q1
$28K Buy
+2,534
New +$28K ﹤0.01% 5089
2020
Q3
Sell
-1,342
Closed -$7K 4460
2020
Q2
$7K Sell
1,342
-7,901
-85% -$41.2K ﹤0.01% 4168
2020
Q1
$49K Buy
+9,243
New +$49K ﹤0.01% 4216
2019
Q4
Sell
-3,844
Closed -$12K 4074
2019
Q3
$12K Buy
3,844
+2,267
+144% +$7.08K ﹤0.01% 4328
2019
Q2
$6K Buy
+1,577
New +$6K ﹤0.01% 4429
2018
Q4
Sell
-1,017
Closed -$5K 3765
2018
Q3
$5K Buy
+1,017
New +$5K ﹤0.01% 3233
2018
Q2
Sell
-32,655
Closed -$137K 3734
2018
Q1
$137K Buy
32,655
+19,571
+150% +$82.1K ﹤0.01% 2938
2017
Q4
$52K Buy
13,084
+11,950
+1,054% +$47.5K ﹤0.01% 3424
2017
Q3
$6K Buy
+1,134
New +$6K ﹤0.01% 3063
2016
Q3
Sell
-2,824
Closed -$25K 3051
2016
Q2
$25K Buy
+2,824
New +$25K ﹤0.01% 3053
2015
Q2
Sell
-1,254
Closed -$20K 4469
2015
Q1
$20K Sell
1,254
-835
-40% -$13.3K ﹤0.01% 4010
2014
Q4
$31K Buy
+2,089
New +$31K ﹤0.01% 4308
2014
Q3
Sell
-1,065
Closed -$33K 3888
2014
Q2
$33K Buy
+1,065
New +$33K ﹤0.01% 4139